Cocrystal Pharma gets FDA fast track status for norovirus drug CDI-988

April 2, 2026 8:00 AM

Cocrystal Pharma, Inc. (NASDAQ: COCP) announced that the U.S. Food and Drug Administration has granted Fast Track designation to CDI-988 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found